Terpineol

DB15956ExperimentalSmall molecule

Terpineol is an ingredient in products that are adjunct in the treatment of upper respiratory tract congestion.

Mechanism: Pharmacologically active on Cannabinoid receptor 1, Cannabinoid receptor 2, and Dopamine receptor D2
Curator reviewed
Formula / weight: C₁₀H₁₈O · 154.253 g/mol (avg)
Code names: 232-268-1

Resolves to

Compound

Clinical / RWD

Structure

InChIKeyWUOACPNHFRMFPN-UHFFFAOYSA-NSMILESCC1=CCC(CC1)C(C)(C)O

Targets

What you can answer from here — as of July 08, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Structured indicationsCondition, population, route and combination as fields, not prose

4ContraindicationsEach with its own population and attribute set

1Marketed productAcross 1 country and 1 labeller

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Terpineol, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.